SCHEMBL4014347

SCHEMBL4014347

O=C(O)C1(C(=O)O)COCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14742645 0.88 FFAR3 (0.32)
SCHEMBL31099417 0.72 FFAR3 (0.32)
SCHEMBL6897680 0.72 FFAR3 (0.50)
SCHEMBL11005333 0.69
Bicarbonate SCHEMBL28191678 0.67
SCHEMBL26699488 0.67 NPSR1 (0.33)
SCHEMBL16837716 0.67
SCHEMBL9708741 0.67 FFAR3 (0.38)
SCHEMBL9708626 0.67 FFAR3 (0.32)
SCHEMBL28281980 0.65 MAPK1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108929304-B Preparation method of trans-2-substituent-5-carboxyl-1, 3-dioxane 正大天晴药业集团股份有限公司 2022-09-20 CN claimed
CN-108929304-B Preparation method of trans-2-substituent-5-carboxyl-1, 3-dioxane 正大天晴药业集团股份有限公司 2022-09-20 CN disclosed
CN-108929304-B Preparation method of trans-2-substituent-5-carboxyl-1, 3-dioxane 正大天晴药业集团股份有限公司 2022-09-20 CN disclosed
US-20220056033-A1 ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS, INC. 2022-02-24 US disclosed
US-11124515-B2 Adenosine receptor antagonists and uses thereof TEON THERAPEUTICS, INC. (US) 2021-09-21 US disclosed
US-20210163483-A1 ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS, INC. 2021-06-03 US disclosed
US-20210040097-A1 ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS, INC. 2021-02-11 US disclosed
CN-106243080-A Use the manufacture method of the carbonyl compound of decarboxylic reaction DIC株式会社 2016-12-21 CN disclosed
WO-2009086192-A1 BIODEGRADABLE PHOSPHATE PROTECTED NUCLEOTIDE DERIVATIVES AND THEIR USE AS CANCER, ANTI VIRAL AND ANTI PARASITIC AGENTS ALIOS BIOPHARMA, INC. (US) 2009-07-09 WO disclosed